- Home
- ICCC vs GROV Comparison
ICCC vs GROV Comparison
Compare ICCC & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- GROV
- Stock Information
- Founded
- ICCC 1982
- GROV 2016
- Country
- ICCC United States
- GROV United States
- Employees
- ICCC N/A
- GROV N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- GROV Package Goods/Cosmetics
- Sector
- ICCC Health Care
- GROV Consumer Discretionary
- Exchange
- ICCC Nasdaq
- GROV Nasdaq
- Market Cap
- ICCC 46.2M
- GROV 57.6M
- IPO Year
- ICCC 1987
- GROV N/A
- Fundamental
- Price
- ICCC $6.83
- GROV $1.34
- Analyst Decision
- ICCC
- GROV Hold
- Analyst Count
- ICCC 0
- GROV 1
- Target Price
- ICCC N/A
- GROV $1.20
- AVG Volume (30 Days)
- ICCC 27.2K
- GROV 118.5K
- Earning Date
- ICCC 05-14-2025
- GROV 05-14-2025
- Dividend Yield
- ICCC N/A
- GROV N/A
- EPS Growth
- ICCC N/A
- GROV N/A
- EPS
- ICCC N/A
- GROV N/A
- Revenue
- ICCC $27,302,766.00
- GROV $193,427,000.00
- Revenue This Year
- ICCC N/A
- GROV N/A
- Revenue Next Year
- ICCC N/A
- GROV $6.19
- P/E Ratio
- ICCC N/A
- GROV N/A
- Revenue Growth
- ICCC 28.29
- GROV N/A
- 52 Week Low
- ICCC $3.34
- GROV $1.02
- 52 Week High
- ICCC $6.95
- GROV $1.95
- Technical
- Relative Strength Index (RSI)
- ICCC 74.94
- GROV 59.55
- Support Level
- ICCC $6.00
- GROV $1.30
- Resistance Level
- ICCC $6.95
- GROV $1.41
- Average True Range (ATR)
- ICCC 0.39
- GROV 0.10
- MACD
- ICCC 0.12
- GROV 0.02
- Stochastic Oscillator
- ICCC 94.12
- GROV 77.72
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.